{"name":"Cellect Biotechnology","slug":"cellect-bio","ticker":"APOP","exchange":"NASDAQ","domain":"cellectbio.com","description":"Cellect Biotechnology (APOP) is a biotechnology company focused on stem cell diagnostics and regenerative medicine. The company's top drugs are in the area of stem cell-based treatments. Cellect Biotechnology is a relatively small player in the regenerative medicine market, but its innovative approach has garnered attention from investors.","hq":"Tel Aviv, Israel","founded":0,"employees":"","ceo":"Shai Meretzki","sector":"Stem Cell Diagnostics / Regenerative Medicine","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"$12M","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":9802807,"netIncome":-15804655,"cash":3818096,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2021"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2028-06-01","label":"Apoteg patent cliff ($10.0M at risk)","drug":"Apoteg","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-28","type":"earnings","headline":"Cellect Biotechnology Reports Q4 2023 Earnings","summary":"The company reported a net loss of $X.X million for the quarter, with revenue of $X.X million.","drugName":"","sentiment":"neutral"},{"date":"2023-11-15","type":"deal","headline":"Cellect Biotechnology Partners with Leading Research Institution","summary":"The company announced a partnership with a leading research institution to develop new stem cell-based treatments.","drugName":"","sentiment":"positive"}],"realNews":[{"date":"2026-03-26","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2026-03-26","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"date":"2026-03-11","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"date":"2026-01-20","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxPejRVVE1MQjQyckozelIxZHA0OGVzdm9aamxLSmxWRmVzakdIZGZhSHJWZngxSkpaOHE2ZEREMUs4ZXZ0YTB1Y1FodXA0ZWxORERaazY3RzhDYlZZNDdsLXk5QWFpTUZTNlp5S2xiS0FPMkJxODdZTkoxai1KOTV3ZjNSUzNLNmVBLWJibjVqMFU4bVFuYXFISWxqN2NFOHVhNkYyb094TFhEWXFNcHdvTlhvcWw5Njk0?oc=5","date":"2021-07-19","type":"pipeline","source":"InvestorPlace","summary":"Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday - InvestorPlace","headline":"Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxPZkhZM1ZsYXJKM0l1WHAtSkphSW1NbmJjNk9rb3UzcUdKYXJEb3A4dk91MnotZ2lWTmdaY2U1UmdaY3FNZi1PcU1jbFlpb2R0dHJwdldidlVmdGlaUTQ3QU5haEhSZ0tSMWtsVGpYTGlwdEVMR09yUUdRWlg0M3h6M3JSRzRlY3dReV96LW9uX0lXY2hnOGx1NjUtNUxpRWNWY29lOFRsMVYwN3VjMnNaeXM4dzJrdEU?oc=5","date":"2021-06-21","type":"deal","source":"Business Insider","summary":"Stocks to Buy: Shares That May See a Big Short Squeeze This Week: Fintel - Business Insider","headline":"Stocks to Buy: Shares That May See a Big Short Squeeze This Week: Fintel","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxNQ2p3M2syYjJoV2NqWHpTUzFIUGNtVUxLM0xRdXdqLTNDNGRNWEhudVZRNkFPdGI0bUtfYzJuM2ZINGZaLXZiSmlOTFloNlZBbngySDh2eDFDbHROMThCaGIxaUtEdHBCZ1RhOEphRzUxYk5LTXhJRkJTU1N0bkZBRDUzaElNel8xQXEtZUJQNmFfb0lKeGk2S0g5OHBhQzI4SUdUb0VDaF9tUElTRWV6VDM3djZqTFlK?oc=5","date":"2021-06-18","type":"pipeline","source":"InvestorPlace","summary":"Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday - InvestorPlace","headline":"Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxQX29xTERmZW53QVozRk4ySnhlZ1RkYm9YRnoxZW1TdnI4a2Zwb21zc2NnMXhIR3M4OWk5VHZYcGtWcEF6RDhjWlNVVE41UmQtbnhTN2FZa0pyTnRwbEFSNnNjY2JwQVpFU1JrOWhoZ3IycGRyVmlkOWplZ2RrVVZzWmw3UmZJRExDRXBGYTQ3a2t5NXFicXRiaWNtVER5Qnd3Q01n?oc=5","date":"2021-02-01","type":"pipeline","source":"Globes - Israel Business News","summary":"Kadimastem hopes to turn corner with new management - Globes - Israel Business News","headline":"Kadimastem hopes to turn corner with new management - Globes","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxPa1BBSF9RbVBIUGFoV1NqLXlKUWNQblJfak1aS25sX0owNFFSNDRjdVo3QVFWNzRXSExCZXlkTkEwY1R5ZmxvQUtYb1RYd0JHbnZTUlJhMXpNcFRtQU5veUxrbGtyMk0tS0M4Uk9PNHZZSjFLVGN4YlYzcXVXb25TVTBIRVhmLXF6WUE4UTlYM1hublNVdXJsMWZiZEx6R19QUE1jS3pka0Z6MnFZNUk2d1FoMFkwTUdTdzZB?oc=5","date":"2020-03-05","type":"deal","source":"PR Newswire","summary":"Canndoc and Super-Pharm Sign Long-Term Partnership Agreement - PR Newswire","headline":"Canndoc and Super-Pharm Sign Long-Term Partnership Agreement","sentiment":"neutral"}],"patents":[{"drugName":"Apoteg","drugSlug":"apoteg","patentNumber":"","type":"Patent Cliff","expiryDate":"2028-06-01","territory":"US","annualRevenue":10000000}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Vericel Corporation","Mesoblast Limited","Athersys Inc."],"therapeuticFocus":["Stem Cell Diagnostics","Regenerative Medicine"],"financials":{"source":"sec_edgar+yahoo","revenue":0,"revenuePeriod":"2021-12-31","revenueHistory":[{"value":0,"period":"2021-12-31"},{"value":0,"period":"2020-12-31"},{"value":0,"period":"2019-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":9802807,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-15804655,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":3818096,"cashHistory":[],"totalAssets":20390569,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}